Suitability depends primarily on the extent of disease, the person’s treatment goals, and reproductive plans. Clinicians must determine whether abnormal tissue can be removed or treated without compromising effective disease management. The decision therefore balances preservation of reproductive potential against the need for adequate treatment, rather than treating fertility preservation as an independent objective.
The reproductive structures retained can influence which aspects of reproductive potential remain available. Keeping the uterus may support the ability to carry a pregnancy, while preserving ovarian tissue may help maintain hormonal function and reproductive potential. Limiting surgery to an affected region can conserve more tissue, but the expected benefit depends on disease extent and individual circumstances.
Fertility preservation cannot replace effective treatment of the underlying disease. Surgical planning must remove or treat abnormal tissue sufficiently while avoiding unnecessary loss of reproductive structures or function. This balance is especially important when disease extent limits what can safely be conserved, because preserving fertility potential is beneficial only when it remains clinically compatible with disease management.
The surgical approach may remove abnormal tissue, treat the affected area, or limit removal to a specific region rather than removing all reproductive structures. The exact plan depends on where and how extensively disease is present. Retaining the uterus or ovarian tissue may be considered when clinically safe, with the goal of conserving relevant reproductive function.
Counseling should address the person’s reproductive plans together with treatment goals and disease-related considerations. This discussion helps clarify which structures or functions might be preserved and what uncertainties remain about future conception or pregnancy. It also supports an individualized decision, since the same surgical strategy may have different significance for people with different family-building plans.
Follow-up evaluates more than the immediate surgical result. Ongoing assessment should consider recurrence risk, hormonal function, and fertility outcomes, because preserving tissue does not guarantee preserved reproductive capability. These measures help clinicians determine whether disease remains controlled and whether the retained reproductive structures continue to support the intended reproductive goals.